Cargando…

Challenges and Opportunities Associated With Platelets in Pancreatic Cancer

Pancreatic cancer is one of the most common malignant tumors in the digestive system with a poor prognosis. Accordingly, better understanding of the molecular mechanisms and innovative therapies are warranted to improve the prognosis of this patient population. In addition to playing a crucial role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zhou, Wei, Xiaodong, Dong, Shi, Han, Fangfang, He, Ru, Zhou, Wence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039220/ https://www.ncbi.nlm.nih.gov/pubmed/35494001 http://dx.doi.org/10.3389/fonc.2022.850485

Ejemplares similares

Pancreatic stellate cells in pancreatic cancer: as potential targets for future therapy
por: Wang, Zhengfeng, et al.
Publicado: (2023)

Association of the Microbiota and Pancreatic Cancer: Opportunities and Limitations
por: Chen, Zhou, et al.
Publicado: (2022)

Neutrophils in pancreatic cancer: Potential therapeutic targets
por: Jiang, Wenkai, et al.
Publicado: (2022)

Understanding Necroptosis in Pancreatic Diseases
por: He, Ru, et al.
Publicado: (2022)

New challenges for microRNAs in acute pancreatitis: progress and treatment
por: Zhou, Wence, et al.
Publicado: (2022)

Nomograms for Predicting the Risk and Prognosis of Liver Metastases in Pancreatic Cancer: A Population-Based Analysis
por: Shi, Huaqing, et al.
Publicado: (2023)

Glucose metabolism and tumour microenvironment in pancreatic cancer: A key link in cancer progression
por: Dong, Shi, et al.
Publicado: (2022)

A nomogram for predicting survival in patients with advanced (stage III/IV) pancreatic body tail cancer: a SEER-based study
por: Shi, Huaqing, et al.
Publicado: (2022)

Understanding Esophageal Cancer: The Challenges and Opportunities for the Next Decade
por: Yang, Jianjun, et al.
Publicado: (2020)

Opportunities and Challenges of the Human Microbiome in Ovarian Cancer
por: Cheng, Huiyan, et al.
Publicado: (2020)

Extracellular Vesicles and Hepatocellular Carcinoma: Opportunities and Challenges
por: Wang, Juan, et al.
Publicado: (2022)

Ferroptosis in Glioma Immune Microenvironment: Opportunity and Challenge
por: Wang, Kaikai, et al.
Publicado: (2022)

UPS: Opportunities and challenges for gastric cancer treatment
por: Yang, Hang, et al.
Publicado: (2023)

Current understanding of ferroptosis in the progression and treatment of pancreatic cancer
por: Dong, Shi, et al.
Publicado: (2021)

Semaphorins and their receptors in pancreatic cancer: Mechanisms and therapeutic opportunities
por: Liu, Dahai, et al.
Publicado: (2023)

COVID-19 vaccination in patients with cancer: Opportunities and challenges
por: Al-qaim, Zahraa Haleem, et al.
Publicado: (2022)

Opportunities and challenges of targeting c-Met in the treatment of digestive tumors
por: Zhang, Zhengchao, et al.
Publicado: (2022)

Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
por: Chen, Zhou, et al.
Publicado: (2023)

Opportunities and challenges of hepatocellular carcinoma organoids for targeted drugs sensitivity screening
por: Xie, Cuiying, et al.
Publicado: (2023)

Opportunities and Challenges for Gut Microbiota in Acute Leukemia
por: Ma, Tao, et al.
Publicado: (2021)

Photodynamic therapy for prostate cancer: Recent advances, challenges and opportunities
por: Xue, Qin, et al.
Publicado: (2022)

Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy
por: Ocáriz-Díez, Maitane, et al.
Publicado: (2020)

Targeting MCL-1 protein to treat cancer: opportunities and challenges
por: Tantawy, Shady I., et al.
Publicado: (2023)

Editorial: Radioimmunotherapy—Translational Opportunities and Challenges
por: Gaipl, Udo S., et al.
Publicado: (2020)

Pancreatic cancer: challenges and opportunities
por: Zhu, Huiyun, et al.
Publicado: (2018)

Editorial: Challenges and opportunities of TKIs in the treatment of NSCLC patients with uncommon mutations
por: Su, Chunxia, et al.
Publicado: (2022)

Targeting integrin α5β1 in urological tumors: opportunities and challenges
por: Zhou, Xuming, et al.
Publicado: (2023)

Kidney Cancer Models for Pre-Clinical Drug Discovery: Challenges and Opportunities
por: Pohl, Laura, et al.
Publicado: (2022)

Metabolic Reprogramming and Epithelial-Mesenchymal Plasticity: Opportunities and Challenges for Cancer Therapy
por: Sun, Nai-Yun, et al.
Publicado: (2020)

Diagnostics and treatment of ovarian cancer in the era of precision medicine - opportunities and challenges
por: Bukłaho, Patrycja Aleksandra, et al.
Publicado: (2023)

T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?
por: Zhou, Qi, et al.
Publicado: (2020)

Opportunities and Challenges for Successful Use of Bevacizumab in Pediatrics
por: Barone, Amy, et al.
Publicado: (2013)

Opportunities and challenges related to ferroptosis in glioma and neuroblastoma
por: Chi, Huizhong, et al.
Publicado: (2023)

Opportunities and Challenges of Nanoparticles in Digestive Tumours as Anti-Angiogenic Therapies
por: Yang, Zhengyang, et al.
Publicado: (2022)

Identification of Genetic Mutations in Cancer: Challenge and Opportunity in the New Era of Targeted Therapy
por: Jin, Jing, et al.
Publicado: (2019)

Various Uses of PD1/PD-L1 Inhibitor in Oncology: Opportunities and Challenges
por: Li, Zhitao, et al.
Publicado: (2021)

A Novel Cuproptosis-Associated Gene Signature to Predict Prognosis in Patients with Pancreatic Cancer
por: Du, Yan, et al.
Publicado: (2023)

Intracranial Metastatic Disease: Present Challenges, Future Opportunities
por: Li, Alyssa Y., et al.
Publicado: (2022)

Big Data in Designing Clinical Trials: Opportunities and Challenges
por: Mayo, Charles S., et al.
Publicado: (2017)

Assessment of Ablation Therapy in Pancreatic Cancer: The Radiologist’s Challenge
por: Granata, Vincenza, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iq28orbskstcjuaomr3gm0nlnh